Swiss Startups

Source of intellectual property and unique expertise for pharmaceutical and biotechnological R&D

Longevity company based on cellular reprogramming.

Development of a new cure for diabetic neuropathy

Pharmaceutical products for patients affected by the build-up of atherosclerotic plaques

Addressing major challenges in antimicrobial therapies.

Development of breakthrough therapies for loss of body weight and muscle mass and anorexia

Next generation pharmacological chaperones treatments

Advancing exosome applications with fast, precise separation

Multi-asset pre-clinical stage Biotech startup

Drug development against severe infections

Impli is developing a hormone monitoring implant for IVF

Improving drug discovery through patient cell screening.